Shares of Antares Pharma (ATRS -9.1%) continue their slide today after its second-quarter loss...

|About: Antares Pharma Inc. (ATRS)|By:, SA News Editor

Shares of Antares Pharma (ATRS -9.1%) continue their slide today after its second-quarter loss widened and results missed analyst estimates on Wednesday. Net profit was hit by bottom line pressure from higher investment expenses related to the development of its Vibex MTX auto injector for the treatment of rheumatoid arthritis, along with an increase in support personnel.